What is the CEAP classification system for chronic venous disease and how are its Clinical, Etiology, Anatomy, and Pathophysiology components defined?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CEAP Classification System for Chronic Venous Disease

The CEAP classification is a standardized system that categorizes chronic venous disease based on four components: Clinical severity (C0-C6), Etiology (congenital, primary, or secondary), Anatomic distribution (superficial, deep, or perforator veins), and Pathophysiology (reflux or obstruction). 1

The Four Components of CEAP

Clinical Classification (C)

The clinical component grades disease severity from C0 to C6, with each class representing progressively more severe manifestations 1:

  • C0: No visible or palpable signs of venous disease 2
  • C1: Telangiectasia (intradermal veins <1 mm diameter) or reticular veins (subdermal veins 1-3 mm diameter) 1
  • C2: Varicose veins (dilated, tortuous subcutaneous veins ≥3 mm diameter in upright position) 1
  • C3: Edema 1
  • C4: Skin changes (subdivided into subclasses) 3, 4
    • C4a: Pigmentation or eczema 3, 4
    • C4b: Lipodermatosclerosis or atrophie blanche 3, 4
    • C4c: Corona phlebectatica (added in 2020 update) 3, 4
  • C5: Healed venous ulcer 1
  • C6: Active venous ulcer 1

The 2020 update introduced important modifiers: the "r" designation for recurrent disease (C2r for recurrent varicose veins, C6r for recurrent active ulcers) 3, 4. Each class can be further designated as asymptomatic or symptomatic 1.

Etiologic Classification (E)

The etiology component identifies the underlying cause of venous disease 1:

  • EC: Congenital venous abnormalities 3, 4
  • EP: Primary venous disease (valvular incompetence without identifiable cause) 1
  • ES: Secondary venous disease 3, 4
    • ESI: Intravenous secondary causes (venous wall/valve damage from prior DVT or other intraluminal pathology) 4
    • ESE: Extravenous secondary causes (extrinsic venous obstruction affecting hemodynamics without wall/valve damage) 4
  • EN: No identifiable cause (diagnosis of exclusion when clinical signs suggest venous disease but no other etiology is found) 4

In clinical practice, primary disease accounts for approximately 79% of cases, while secondary disease (predominantly post-thrombotic) represents 18% 5. Notably, ulcers occur in only 7% of primary disease cases but in 44% of secondary disease cases 5.

Anatomic Classification (A)

The anatomic component specifies which venous segments are involved 1:

  • Superficial veins: Including great saphenous vein, small saphenous vein, and tributaries 1
  • Deep veins: Including femoral, popliteal, and tibial veins 1
  • Perforator veins: Connecting superficial and deep systems 1

The 2020 update replaced numeric descriptions with common anatomic abbreviations (e.g., GSV for great saphenous vein) to improve clarity and ease of use 3, 4.

Pathophysiologic Classification (P)

The pathophysiology component identifies the functional abnormality 1:

  • PR: Reflux (accounts for 86% of all cases and 80% of ulcer cases) 5
  • PO: Obstruction 1
  • PR,O: Combined reflux and obstruction 2
  • PN: No identifiable venous pathophysiology 2

Clinical Application and Significance

The CEAP system provides standardized terminology for clinical documentation, research reporting, and treatment planning 1. The 2004 revision introduced both a "basic" version (using only C, E, A, P descriptors) and an "advanced" version with detailed anatomic segment notation to balance simplicity with specificity 2.

Key Clinical Correlations

The classification reveals important disease patterns 5:

  • Reflux is the dominant pathophysiology across all severity levels 5
  • Secondary (post-thrombotic) disease carries higher risk of ulceration than primary disease 5
  • The prevalence of C2-C3 disease is approximately 25%, while C4-C6 disease affects about 5% of the population 1

Important Limitations

CEAP is a descriptive classification system, not a severity scoring tool 2, 6. For longitudinal assessment of treatment outcomes, separate venous severity scoring systems and quality of life instruments should be used 2. Additionally, C2 encompasses all types of varicose veins without distinguishing severity, and C3 may include non-venous causes of edema 6.

The classification requires objective diagnostic testing (duplex ultrasound, plethysmography, or venography) for accurate anatomic and pathophysiologic designation 5, though clinical classification alone can be applied based on physical examination 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.